On March 15, 2017, the ADPH voted upon the question of rescheduling Xanax, deciding to move the drug from its current position on the Schedule of Controlled Substances to a level II (CS II). Other benzodiazepines were moved to CS III. This change was proposed by the Alabama Board of Medical Examiners (ALBME) and approved by the State Public Health Committee.
In a meeting of the Legislative Council of Alabama on April 13, 2017, the question of reclassifying Xanax as a CS II (from CS IV) was considered and voted upon following a public hearing.
After testimony and discussion, the Council
did not vote to reclassify Xanax, retaining its classification as a CS IV.
Help keep NPAA working for you!
Join NPAA to stand with us to make a difference in Alabama!
11th Annual NPAA Conference
Speaker Highlight: Dr. Michele Talley
The Nurse Practitioner Alliance of Alabama (NPAA) will hold its 11th Annual Advanced Nursing Practice Conference on October 27-28th, 2017 at the Hyatt Wynfrey Conference Center in Birmingham, AL (located at Galleria Mall).
Dr. Michele Talley, Assistant Professor and MSN Program Director at the UAB School of Nursing, will be a speaker at the NPAA conference. She has a long time educational interest in caring for patients with diabetes, but more so, for patients who are indigent with diabetes. For five years, Dr. Talley has led an interdisciplinary team that was developed to provide comprehensive care to uninsured patients with diabetes. Dr. Talley will share updated information on the treatment of diabetes and work through case studies to reinforce the material.
Diabetes mellitus is the seventh leading cause of death in the United States. It also is a leading cause of morbidity, resulting in both microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular (coronary artery, cerebrovascular, and peripheral vascular disease) complications.
The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on oral pharmacologic treatment of type 2 diabetes in adults. This guideline serves as an update to the 2012 ACP guideline on the same topic. This guideline is endorsed by the American Academy of Family Physicians.
Please take a moment to update your contact information at the link at the bottom of this news brief so that we may continue to provide you with the most up-to-date information regarding NP practice in Alabama!
Thank you for all of your continued support!!If you would like to learn more about getting more involved with NPAA, please do not hesitate to contact us (link below).